Membrane biocompatibility does not affect whole body protein metabolism during dialysis

Blood Purification

Volumn 23, Issue 3, 2005, Pages 211-218

  Veeneman, Jorden M ^a,b   Kingma, Hermi A ^a   Stellaard, Frans ^a,b   De Jong, Paul E ^a,b   Reijngoud, Dirk Jan ^a,b   Huisman, Roel M ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Amino acid; Hemodialysis; Protein turnover; Stable isotope; Valine

Indexed keywords

CELLULOSE; CUPROPHANE; POLYSULFONE;

ADULT; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; MALE; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN METABOLISM;

AMINO ACIDS; BIOCOMPATIBLE MATERIALS; FEMALE; HUMANS; MALE; MEMBRANES, ARTIFICIAL; PROTEINS; RENAL DIALYSIS;

EID: 21044438044     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084891     Document Type: Article

References (21)

1. Lim VS, Kopple JD: Protein metabolism in patients with chronic renal failure: Role of uremia and dialysis. Kidney Int 2000;58:1-10.
2. Veeneman JM, Kingma HA, Boer TS, et al: Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients. Am J Physiol Endocrinol Metab 2003;284:E954-E965.
3. Gutierrez A, Bergstrom J, Alvestrand A: Protein catabolism in sham-hemodialysis: The effect of different membranes. Clin Nephrol 1992;38:20-29.
4. Lim VS, Bier DM, Flanigan MJ, Sum PS: The effect of hemodialysis on protein metabolism. A leucine kinetic study. J Clin Invest 1993;91: 2429-2436.
5. Shaldon S, Elie M, Koch KM, Dinarello CA: Interleukin-1 stimulation in the ESRD patient: Potential long-term consequences. Transplant Proc 1987;19:4353-4357.
6. Kaysen GA: The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 2001;12:1549-1557.
7. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990;38:487-494.
8. Gutierrez A, Bergstrom J, Alvestrand A: Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid. Kidney Int 1994;46:814-822.
9. Parker TF, Wingard RL, Husni L, et al: Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 1996;49:551-556.
10. Jager KJ, Merkus MP, Huisman RM, et al: Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 2001;12: 1272-1279.
11. Locatelli F, Mastrangelo F, Redaelli B, et al: Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 1996;50:1293-1302.
12. Lofberg E, Essen P, McNurlan M, et al: Effect of hemodialysis on protein synthesis. Clin Nephrol 2000;54:284-294.
13. Lim VS, Flanigan MJ: Protein intake in patients with renal failure: Comments on the current NKF-DOQI guidelines for nutrition in chronic renal failure. Semin Dial 2001;14: 150-152.
14. Livesey JH, Hodgkinson SC, Roud HR, Donald RA: Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin Biochem 1980;13:151-155.
15. 13C]leucine infusion in man: A method for measuring human intracellular leucine tracer enrichment. Metabolism 1982;31:1105-1112.
16. Veeneman JM, Kingma HA, Boer TS, et al: The metabolic response to ingested protein is normal in long-term hemodialysis patients. Am J Kidney Dis 2004;43:330-341.
17. Navarro JF, Marcen R, Teruel JL, et al: Effect of different membranes on amino-acid losses during haemodialysis. Nephrol Dial Transplant 1998;13:113-117.
18. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM: Amino acid and albumin losses during hemodialysis. Kidney Int 1994;46:830-837.
19. Navarro JF, Mora C, Leon C, et al: Amino acid losses during hemodialysis with polyacrylonitrile membranes: effect of intradialytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients. Am J Clin Nutr 2000;71: 765-773.
20. Memoli B, Minutolo R, Bisesti V, et al: Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes. Am J Kidney Dis 2002;39:266-273.
21. Kobayashi H, Borsheim E, Anthony TG, et al: Reduced amino acid availability inhibits muscle protein synthesis and decreases activity of initiation factor eIF2B. Am J Physiol Endocrinol Metab 2003;284:E488-E498.